---
title: "MAYER ARIE — Ownership Dossier"
canonical: https://whiteintel.dev/entity/c1924b06-b04c-5d18-8b8f-6cebf8a84687
json: https://whiteintel.dev/api/public/dossier/c1924b06-b04c-5d18-8b8f-6cebf8a84687
identifier: sec:0001796583
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# MAYER ARIE

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001796583`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/c1924b06-b04c-5d18-8b8f-6cebf8a84687  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/c1924b06-b04c-5d18-8b8f-6cebf8a84687  

## Ownership & control

### Holdings / subsidiaries

- **ORAMED PHARMACEUTICALS INC.** (director) — https://whiteintel.dev/entity/88a43028-7c7b-5d93-b0bb-edce2492b7dc

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **MAYER ARIE**. Human view: https://whiteintel.dev/entity/c1924b06-b04c-5d18-8b8f-6cebf8a84687 · Structured JSON: https://whiteintel.dev/api/public/dossier/c1924b06-b04c-5d18-8b8f-6cebf8a84687._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._